A recent study unveiled a novel sinus node ablation technique that provides a safe and effective treatment option for patients suffering from symptomatic, drug-resistant inappropriate sinus tachycardia (IST).
Results from a new clinical trial show an increased risk of cardiac events, like sudden cardiac death (SCD), among women with congenital long QT syndrome (LQTS) who are taking progestin-only oral contraceptives (OC) without beta-blocker therapy.
Findings from a new, multi-center clinical trial reveal a novel 4- Dimension (4D) ICE catheter provides a simple, intuitive field of view during catheter ablation and left atrial appendage closure procedures.
Results from an international clinical trial show a significant reduction in risk of ventricular tachycardia (VT) recurrence, cardiovascular hospitalization, and death when catheter ablation is used as an early first-line treatment for patients with structural heart disease.
A new study shows direct oral anticoagulants (DOACS) are more effective than aspirin (ASA) in reducing cerebrovascular events (CVE), including transient ischemic attack and stroke in patients undergoing ventricular tachycardia using radiofrequency catheter ablation (RFA).
The American College of Cardiology and Heart Rhythm Society, in collaboration with the Bristol Myers Squibb-Pfizer Alliance, are launching an innovative project to improve management of atrial fibrillation in underserved communities.